ArticleCardiovascular diabetology2026
An interpretable machine learning model for predicting postoperative hypotension in type 2 diabetes mellitus undergoing non‑cardiac surgery.
Article in Cardiovascular diabetology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundPostoperative hypotension (POH) is a common and serious complication in patients with type 2 diabetes mellitus (T2DM) undergoing non‑cardiac surgery, yet predictive tools tailored to this high‑risk population remain scarce.
methodsThis single‑center cohort study developed and validated a machine learning (ML) model to predict the risk of postoperative hypotension (POH) occurring during the post‑anaesthesia care unit (PACU) stay, defined as systolic blood pressure < 90 mmHg after leaving the operating theatre and before transfer to the general ward, consistent with the Perioperative Quality Initiative (POQI) consensus. Data from 34,012 retrospective (2012-2022) and 10,528 prospective (2023-2025) T2DM patients undergoing non‑cardiac surgery were used. Following rigorous preprocessing and a four‑step feature selection, 13 predictors were retained. Fourteen ML models were trained and evaluated using area under the curve (AUC), sensitivity, specificity, and calibration. Model interpretability was enhanced using SHapley Additive exPlanations (SHAP).
resultsRandom Forest achieved the best overall performance, with AUCs of 0.843 (95% CI 0.837-0.849) on training, 0.854 (95% CI 0.848-0.860) on internal validation, and 0.847 (95% CI 0.840-0.854) on prospective validation. External validation on an independent hospital cohort (n = 2156) yielded an AUC of 0.822 (95% CI 0.805-0.839), confirming generalisability. It demonstrated high sensitivity (0.932) and reliable calibration. SHAP analysis identified intraoperative blood loss, age, heart failure, obstructive sleep apnoea, and body mass index as the top predictors, providing transparent global and local explanations for individual risk.
conclusionAn interpretable ML model based on routinely collected clinical data accurately predicts POH risk in T2DM patients after non‑cardiac surgery. The model combines strong discriminative performance with clinical explainability, suggesting its potential as a practical tool for preoperative risk stratification and personalized postoperative monitoring in T2DM patients within similar clinical settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.